SCHEMBL20161423

SCHEMBL20161423

CNC(=O)c1cc(Sc2cnc(N)s2)c(C)cc1OC

nearest known ligand 0.47

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
JAK3 P52333 13/20 0.47
BTK Q06187 12/20 0.47
TXK P42681 11/20 0.47
ITK Q08881 10/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5655948 0.89 JAK3 (0.48) JAK3BTKTXKITK
SCHEMBL5657783 0.87 JAK3 (0.47) JAK3BTKTXKITK
SCHEMBL29932902 0.87 JAK3 (0.47) JAK3BTKTXKITK
SCHEMBL24467238 0.84 JAK3 (0.66) JAK3BTKTXKITK
SCHEMBL20161851 0.83 JAK3 (0.53) JAK3BTKTXKITK
SCHEMBL20162005 0.81 JAK3 (0.39) JAK3BTKTXKITK
SCHEMBL24467260 0.81 ITK (0.72) JAK3BTKTXKITK
SCHEMBL14460569 0.79 ITK (0.70) JAK3BTKTXKITK
SCHEMBL30291400 0.79 ITK (0.70) JAK3BTKTXKITK
SCHEMBL14460588 0.79 ITK (0.60) JAK3BTKTXKITK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3534899-B1 COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE CORVUS PHARMACEUTICALS INC (US) 2022-06-01 EP disclosed
WO-2018089261-A2 COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE CORVUS PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed